Minidiab tablet 5 mg 30?s lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently.
Side effects
Major & minor side effects for Minidiab tablet 5 mg 30?s

Diarrhea

Dizziness

Shaking of body

Skin Rash

Yellowing of skin and eyes severe

Dark colored urine severe

Pain in upper abdomen severe

Unusual bleeding severe

Fever severe

Excessive air or gas in stomach

Hypoglycemia

Decreased heartbeat severe

Elevated liver enzymes

Uses of Minidiab tablet 5 mg 30?s
What is it prescribed for?

Type II Diabetes Mellitus
This medicine is used individually or in combination with other medications to lower blood glucose levels in patients with type II diabetes mellitus.

Concerns

Frequently asked questions

Onset of action
The effect of this medicine can be observed within 30 minutes of administration of the dose.

Duration of Effect
The effect of this medicine lasts for 12-24 hours.

Safe with Alchohol?
Consumption of alcohol in large quantities is not recommended when you are taking this medicine for controlling blood sugar levels. It is recommended to reduce the alcohol intake so that the adverse effects can be avoided. Symptoms of both reduced or elevated blood sugar levels should be reported to the doctor immediately.

Is it habit forming?
No habit forming tendencies were reported.

Usage in pregnancy?
Use of this medicine in pregnant women is not recommended unless absolutely necessary. It should be used only when the benefits clearly outweigh the risks involved. It is advised to consult your doctor before taking this medicine.

Usage while breast-feeding?
Use of this medicine is not recommended while breastfeeding. Monitoring of the infant for signs of decreased blood sugar may be required if this medicine is taken. You should consult your doctor before taking this medicine.

When not to use?

Allergy
It is not recommended for use if you have a known history of allergy to Minidiab tablet 5 mg 30?s (the primary constituent of Minidiab tablet 5 mg 30?s ) or any other medicine belonging to the group sulphonylurea.

Type I Diabetes mellitus
This medicine is not recommended for use if you have type I or insulin dependent diabetes mellitus.

Diabetic ketoacidosis
This medicine is not recommended for use in a patient having high levels of acid content in the blood.

Warnings

Warnings for special population

Pregnancy
Use of this medicine in pregnant women is not recommended unless absolutely necessary. It should be used only when the benefits clearly outweigh the risks involved. It is advised to consult your doctor before taking this medicine.

Breast-feeding
Use of this medicine is not recommended while breastfeeding. Monitoring of the infant for signs of decreased blood sugar may be required if this medicine is taken. You should consult your doctor before taking this medicine.

General Warnings

Hypoglycemia
This medicine can cause moderate to severe lowering of blood glucose levels. The risks are even greater for the elderly, people who are malnourished, and people suffering from kidney/pituitary gland disorders. You should report any such incidence to the doctor. Carry a reliable source of glucose like sugar candy to counteract the effect of low blood sugar levels.

Stress
This medicine should be discontinued and alternative measures to lower blood sugar should be initiated if you have a high level of stress. Stress may be due to an infection, fever, trauma or a recent surgery. Report any such instance to the doctor.

Liver disease
This medicine should be used with caution if you have a liver disease or the normal function of the liver is impaired.

Kidney disease
This medicine should be used with caution if you have a kidney disease or the normal function is impaired.

Heart disease
This medicine has been associated with severe adverse effects on the heart and blood vessels. It should be used with extreme caution in such patients. Otherwise, alternate medicines to control blood sugar levels should be considered. Report any historic or active incidence of heart disease to the doctor before receiving this medicine.

Hemolytic anemia
This medicine can cause Hemolytic Anemia if you have a rare genetic disorder called G6PD Deficiency.

Gastro-intestinal blockage
This medicine should be used with extreme caution in a patient having bowel movement disorders due to a blockage or narrowing of food pipe.

Alcohol use
Use of alcohol while taking this medicine is not recommended as the risk of rapid fall or rise in blood sugar levels is significantly high.

Photo-sensitivity
This medicine may cause allergic skin reactions when exposed to the sun. Take precautionary measures while you are taking this medicine.

Change of medication
You may experience some temporary side effects if there is a change in current medication used for diabetes. This overlapping effect is because of the change from one medicine to another. Regular monitoring of blood sugar levels might be required in these cases.

Use in children
This medicine is not recommended for use in people below 18 years of age.

Diet and exercise
recommended

Dosage

Missed Dose
Take the missed dose 30 minutes before the next meal. However, if it is almost time for the next scheduled dose then the missed dose should be skipped to prevent overdosing.

Overdose
Contact your doctor immediately if an overdose is suspected. Symptoms of overdose may include weakness, shaking of the body, blurred vision, excessive sweating, stomach pain, and seizures. Sometimes, an overdose of Minidiab tablet 5 mg 30?s may cause a rapid fall in blood sugar levels that could be life threatening.

Interactions
Interaction with Medicines

Atenolol moderate

Gatifloxacin severe

Miconazole moderate

Ethinyl Estradiol moderate

Selegiline moderate

Ibuprofen moderate

Disease interactions

severe
This medicine should be administered with extreme caution if you suffer from a disease of heart or blood vessels. Risk of severe to fatal adverse effects is very high in such patients. Both the clinicians and patients should be aware of the risks before deciding the appropriate therapy.

severe
This medicine should not be used in patients having high acid content in blood as the risk of adverse effects is very high. It applies to both comatose and normal patient with ketoacidosis.

severe
This medicine should be administered with extreme caution if you suffer from any disease of the kidneys. You should consult your doctor to make a suitable adjustment in dosage quantity and/or time-interval between two dosages.

severe
This medicine should be administered with extreme caution if you suffer from any disease of the liver. You should consult your doctor to make a suitable adjustment in dosage quantity and/or time-interval between two dosages.

moderate
This medicine should be administered with caution if you are prone to having episodes of low blood sugar. This population includes diabetics who are also malnourished or those receiving Beta-blocker drugs such as Metoprolol and Propranolol.

moderate
This medicine is not recommended for use in people suffering from Hemolytic Anemia. Reporting this condition to the doctor is a must. In such cases, alternate medication not belonging to Sulfonylureas should be considered.

General Instructions

Take this medicine as instructed by the doctor. Your dosage is likely to change over time based on the response to the medication. Do not take this medicine in larger or smaller quantities than recommended. This medicine should be taken 30 minutes before the first meal of the day. Regular exercise, controlled diet and frequent monitoring of blood sugar levels are recommended while taking any anti-diabetic medicine.

Other details

To be taken before food

To be taken as instructed by doctor

May cause sleepiness

References

medlineplus.gov –
Glipizide [Internet].
Available from: https://medlineplus.gov/druginfo/meds/a684060.html
[cited 5/8/2020].
2020